ULTRAGRIS-165 Detail

Drug Name(s):
ULTRAGRIS-165

FDA Application No.:
NDA 062645

Active Ingredient(s):
GRISEOFULVIN, ULTRAMICROCRYSTALLINE

Company:
PLIVA

Original Approval or Tentative Approval Date:
May 10, 1994

Products on Application NDA 062645:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
GRISEOFULVIN, ULTRAMICROCRYSTALLINE	165MG	TABLET; ORAL	Discontinued	none

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

January 2009

ULTRAGRIS-165 Detail

Sponsored Links

Recall Notices

Action Alerts

Active forum topics

Poll

Subscribe to our feed

Welcome

Diseases & Conditions

Navigation

Resources

Medical Dictionary

Drug Information

Events

Who's online

Job search